Department of Chemistry, Swarthmore College, Swarthmore,
Pennsylvania (D.K., H.G., R.K.P., J.G.V.); Department of Pharmacology,
University of California at San Diego, La Jolla, California (N.A.H.,
P.T.); and Departments of Neurobiology (I.S.) and Structural Biology
(J.L.S.), Weizmann Institute of Science, Rehovot, Israel
Acetylcholinesterase (AChE), a serine hydrolase, is potentially
susceptible to inactivation by phenylmethylsulfonyl fluoride (PMSF) and
benzenesulfonyl fluoride (BSF). Although BSF inhibits both mouse and
Torpedo californica AChE, PMSF does not react measurably with the T. californica enzyme. To
understand the residue changes responsible for the change in
reactivity, we studied the inactivation of wild-type T.
californica and mouse AChE and mutants of both by BSF and PMSF
both in the presence and absence of substrate. The enzymes investigated
were wild-type mouse AChE, wild-type T. californica
AChE, wild-type mouse butyrylcholinesterase, mouse Y330F, Y330A, F288L,
and F290I, and the double mutant T. californica F288L/F290V (all mutants given T. californica
numbering). Inactivation rate constants for T.
californica AChE confirmed previous reports that this enzyme is
not inactivated by PMSF. Wild-type mouse AChE and mouse mutants Y330F
and Y330A all had similar inactivation rate constants with PMSF,
implying that the difference between mouse and T.
californica AChE at position 330 is not responsible for their
differing PMSF sensitivities. In addition, butyrylcholinesterase and
mouse AChE mutants F288L and F290I had increased rate constants (~14
fold) over those of wild-type mouse AChE, indicating that these
residues may be responsible for the increased sensitivity to
inactivation by PMSF of butyrylcholinesterase. The double mutant T. californica AChE F288L/F290V had a rate constant
nearly identical with the rate constant for the F288L and F290I mouse
mutant AChEs, representing an increase of ~4000-fold over the
T. californica wild-type enzyme. It remains unclear why
these two positions have more importance for T.
californica AChE than for mouse AChE.
 |
Introduction |
Acetylcholinesterase
(AChE) is the enzyme that terminates the transmission of nerve impulses
in cholinergic synapses by hydrolyzing the neurotransmitter
acetylcholine to acetic acid and choline. AChE is a serine esterase
with a catalytic mechanism resembling that of serine proteases such as
trypsin. It possesses a high specific activity, functioning at a rate
approaching that of a diffusion-controlled reaction (Voet and Voet,
1995
). Inhibition of AChE is important both medically and
toxicologically. Certain substances that covalently inhibit AChE are
used as insecticides and as chemical warfare agents. Some inhibitors
are used to treat various disorders such as myasthenia gravis and as a
symptomatic approach to the management of Alzheimer's disease (Millard
and Broomfield, 1995
; Taylor, 1998
).
The X-ray crystal structure of Torpedo californica AChE was
determined by Sussman et al. (1991)
. The structure revealed that the
active site of T. californica AChE is located at the bottom of a narrow gorge approximately 20 Å deep and 4.4 Å in diameter at
its narrowest. The active site gorge penetrates halfway into the enzyme
and widens out close to its base. The van der Waals diameter of a
tetramethylammonium ion is 6.4 Å, making this and other quaternary
ammonium ions, such as acetylcholine (ACh) too large to enter the gorge
(Axelsen et al., 1994
). Substrates may gain access to the active site
only if conformational changes occur with those residues that make up
the gorge. The X-ray crystal structure of mouse AChE has also been
determined by Bourne et al. and has the same general active site gorge
structure as the T. californica enzyme (Bourne et al.,
1999
).
The active site contains a catalytic triad consisting of Ser200,
His440, and Glu327. (Note: mammalian and T. californica
AChEs have different numbering schemes. For consistency, the T. californica numbering scheme will be used throughout this
article.) The triad is similar to that of trypsin and other serine
proteases. However, the AChE triad has opposite stereochemistry
to that of trypsin and contains Glu instead of the Asp that is in
trypsin. The walls of the active site gorge are lined primarily by
fourteen aromatic amino acid residues. Two of these residues (Trp84 and
Phe330) interact with the quaternary ammonium ion of ACh (Axelsen et
al., 1994
).
In addition to AChE, most vertebrates have butyrylcholinesterase
(BChE; an enzyme with a still-undetermined biological function), which
hydrolyzes butyrylcholine in a manner similar to AChE hydrolysis of
ACh. In fact, AChE is also able to hydrolyze butyrylcholine, although
much more slowly than BChE, and BChE is able to hydrolyze ACh (Harel et
al., 1992
). Residues 4 to 534 of T. californica AChE can be
aligned with residues 2 to 532 of mammalian BChE with more than 50%
identity and no additions or deletions. In addition, the catalytic
triad residues are in basically the same positions in both enzymes.
Only 10 amino acids that have side chains facing the active site gorge
differ between AChE and BChE. If the amino acid sequence of T. californica AChE and mammalian BChE are compared, there are two
crucial residue changes (BChE residues are given in parentheses): Phe
288 (Leu) and Phe 290 (Ile or Val).
Both phenylmethylsulfonyl fluoride (PMSF) and benzene sulfonyl fluoride
(BSF) are potential inhibitors of AChE. The sulfonyl group of PMSF and
BSF mimics the carbonyl group of the ACh transition state (Fig.
1). The hydroxyl group of Ser200
nucleophilically attacks the sulfonyl group of PMSF or BSF, resulting
in irreversible sulfonylation of AChE.
It has been reported that PMSF inactivates mouse AChE but does
not react measurably with the enzyme from electric fish (eel or
T. californica) (Fahrney and Gold, 1963
; Barnett and
Rosenberry, 1978
; Moss and Fahrney, 1978
). In contrast, BSF inhibits
both mouse and fish AChE. PMSF has an extra methylene compared with BSF, and this extra carbon atom produces a profound change in inactivation of the fish enzyme. If the sequence of T. californica AChE is compared with that of mouse AChE, only five
residues differ within the active site (mouse residues and numbering
are given in parentheses): Glu 73 (Thr 75), Gln 74 (Leu 76), Ser 81 (Thr 83), Ser 124 (Ala 127), and Phe 330 (Tyr 337). The difference in
reactivity may be caused by these few residue changes within the active
sites or by the differing conformations of the active sites of the enzymes.
(
)-Huperzine A, a reversible inhibitor of AChE used in Chinese herbal
medicines, has been shown to bind 25 times more tightly to mouse AChE
than to the T. californica enzyme. However, the mouse Y330F
mutant (T. californica numbering) has an affinity similar to
that of the T. californica enzyme, indicating that the
difference in amino acid at this position is an important contributor
to the specificity for this drug (Saxena et al., 1994
). We therefore
undertook to examine the basis of the differing specificity of mouse
and T. californica AChEs for PMSF, focusing first on the
contribution of position 330. We also studied the effect of mutations
at positions 288 and 290 on the PMSF specificity of the two enzymes.
Positions 288 and 290 are located in the acyl pocket of the enzyme and
are important in determining whether the enzyme is more specific for
acetyl- or butyrylcholine. The specific enzymes we investigated were
wild-type mouse AChE, wild-type T. californica AChE,
wild-type mouse butyrylcholinesterase, and mouse Y330F, Y330A, F288L,
and F290I (Radic et al., 1993
; Vellom et al., 1993
), and the double
mutant T. californica F288L/F290V (Harel et al., 1992
).
Figure 2 shows the relationship of these residues at the active site with PMSF modeled into the site for orientation.

View larger version (90K):
[in this window]
[in a new window]
|
Fig. 2.
The active site of T. californica AChE
showing the active-site Ser(200) and the residues 288, 290, and 330. PMSF is modeled into the site for orientation.
|
|
 |
Materials and Methods |
Chemicals.
PMSF and BSF were purchased from Aldrich Chemical
Company (Milwaukee, WI). All other chemicals were purchased from Sigma
Chemical Company (St. Louis, MO) or Fisher Chemical Company
(Pittsburgh, PA).
Enzymes.
The following enzymes were used: wild-type mouse
AChE; four mutants of this wild-type enzyme (Y330A, Y330F, F288L, and
F290I) (Radic et al., 1993
); AChE from T. californica;
wild-type mouse BChE; recombinant wild-type AChE from T. californica; and the double mutant F288L/F290V AChE from T. californica (Harel et al., 1992
). AChE from T. californica was a kind gift of Drs. Jean Massoulié and
Suzanne Bon (Laboratorie of Neurobiologie, Ecole Normale
Supérieure, Paris, France).
AChE Assay.
The assay was conducted as described in Ellman
et al. (1961)
, using the following final reagent and enzyme
concentrations: 0.5 mM acetylthiocholine chloride (ATC), 0.1 mM
2,2'-dithionitrobenzoic acid in 0.1 M potassium phosphate buffer, pH
7.4, and enzyme with an activity of about 0.1
Abs412/min/ml. The absorbance at 412 nm was
measured for 1 min on a Cary Varian UV/Vis spectrophotometer. Units
correspond to
Abs412/min.
AChE Inactivation in the Absence of Substrate.
The enzyme
was diluted in 0.1 M phosphate buffer to an activity of approximately 2
Abs412/min/ml immediately before the
experiment. Solutions of PMSF and BSF were prepared in methanol on the
day of use. Inactivation reactions were carried out by adding 2.5 µL
of inactivator solution to 0.5 ml of enzyme solution and incubating the
mixture at 25°C. Aliquots (50 µl) were removed and diluted into
assay medium (0.95 ml of assay medium in a 1.0 ml cuvette) every 2 to 4 min thereafter. Residual enzyme activity of each aliquot was measured
by absorbance over 1 min at 412 nm.
Analysis of Data for AChE Inactivation in the Absence of
Substrate.
The mechanism of inactivation of AChE by BSF is assumed
to involve the formation of a reversible enzyme-inhibitor complex followed by the covalent modification of the enzyme (Scheme
1).
The fractional activity (FA) for this scheme is:
where v0 and vt are
the velocities of the enzymatic reaction at times 0 and t, and
|
(1)
|
The natural logarithm of FA versus time was plotted and
the value of k' determined.
Then by plotting k' versus [I], the values of
k2 and KI were
determined for the inactivation of the enzyme by a nonlinear least-squares fit of the data to eq. 1 using KaleidaGraph 3.0 (Synergy
Software, Reading, PA).
k2/KI is the
second-order rate constant for the inactivation of free enzyme by inhibitor.
AChE Inactivation in the Presence of Substrate.
The
reaction mixture included 0.01 to 0.6 mM ATC and 1.0 mM
2,2'-dithionitrobenzoic acid in 0.1 M phosphate buffer, pH 7.4. Enzyme
solution made with 0.1 M phosphate buffer, pH 7.4, was added to the
reaction mixture to give an approximate activity of 0.005-0.05
Abs/min/ml. PMSF and BSF solutions were freshly prepared in methanol
with final concentrations in the reaction mixture ranging from 0.006 to
1.5 mM. The final methanol concentration was 0.1 to 0.5%. The
reactions were carried out at 25°C. The absorbance at 412 nm was
measured for 15 to 60 min using a Cary Varian UV/Vis spectrophotometer.
Km values for ATC were determined using ATC without inhibitor present.
Analysis of Data for AChE Inactivation in the Presence of
Substrate.
Inactivation assays were performed on mutant mouse and
T. californica AChE using an in situ procedure for measuring
the inactivation rates as described by Hart and O'Brien (1973)
. This
procedure is based on using a system containing enzyme, inhibitor, and
substrate. The general scheme for this system is as shown in Scheme
2, where I is the inhibitor, which in
this case is PMSF or BSF. Kinetic analysis of the reactions gives the
following equations (Hart and O'Brien, 1973
)
|
(2)
|
or
|
(3)
|
where k2 is the rate constant of
sulfonylation of enzyme by PMSF, KI is the
dissociation constant of PMSF, k' is the pseudo-first-order rate constant for the disappearance of active enzyme, and
is given
by the following equation:
|
(4)
|
where [S] is the concentration of substrate and
Km is the Michaelis constant of the enzyme
for ATC.
The values of
k2/KI were
obtained from a plot of 1/[I] versus 1/k' according to eq.
2 or from a plot of 1/(1
) versus [I]/k' according to eq. 3.
k' was determined by one of two methods. Method 1: the
derivatives of the graph of concentration of final product
(thionitrobenzoate) with respect to time in both the presence and
absence of inactivator were calculated. These derivatives are equal to
the enzyme activity as a function of time, and yield FA. Plotting
ln(FA) versus t yields k' values for each concentration of
inhibitor, I. Method 2: integrating the FA equation
gives the equation:
where C is a constant of integration. If the rate of nonenzymic
hydrolysis of ATC (kh) is taken into
account, then the equation becomes
|
(5)
|
A412 is plotted versus time and,
using KaleidaGraph 3.0, a nonlinear regression to eq. 5 yields the
value for k', with an R2
typically greater than 0.99.
If substrate concentration is kept constant and inhibitor
concentration is varied, a plot of 1/[I] versus 1/k'
yields a straight line with a slope equal to
[k2 (1
)]/KI and a y-intercept of
(1
)/KI, as depicted in eq. 2. Similarly,
if inhibitor concentration is kept constant but substrate concentration
is varied, a plot of 1/(1
) versus [I]/k'
yields a straight line with slope
k2/KI and
intercept
[I]/KI, as depicted in eq. 3.
The value of Km for ATC was determined
under the conditions described in the AChE assay above, but with
[ATC] varying from 0.01 to 0.6 mM. The initial rate of substrate
hydrolysis was plotted against [ATC], and the data were analyzed
using a nonlinear curve fit to the Michaelis-Menten equation.
Using eq. 2 or eq. 3, k', and the measured value of
Km to determine
, it was possible to
determine k2 and
KI values and the second-order rate
constant for inactivation
(k2/KI).
 |
Results and Discussion |
The Km values we obtained for each of
the enzymes studied is shown in Table 1,
along with their reported relative turnover numbers.
Figure 3 shows a representative plot for
the inactivation of mouse AChE by 4 mM BSF or 0.5 mM PMSF in the
absence of substrate. The reactions follow pseudo-first-order kinetics
with rate constants, k', indicated on the graph. PMSF is the
more reactive inactivator, as shown by the 8-fold higher BSF
concentration necessary to achieve even a 6-fold slower inactivation
than that using PMSF.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 3.
Semilog plot for the FA of wild-type mouse AChE as a
function of time in the presence of 4 mM BSF ( ) or 0.5 mM PMSF
( ).
|
|
Figure 4 shows a representative
time plot for the inactivation of T. californica AChE by 4 mM BSF or 4 mM PMSF in the absence of substrate. The time course for
inactivation of the enzyme in the presence of 0.5% methanol is shown
for comparison.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 4.
Semilog plot for the FA of T.
californica AChE as a function of time in the presence of 4 mM
BSF ( ) or 4 mM PMSF ( ). The inactivation of T.
californica AChE by 0.5% methanol (×) is shown as a
control.
|
|
As first reported by Fahrney and Gold (1963)
, Fig. 4 shows that BSF is
clearly the more reactive inactivator of T. californica AChE. In fact, PMSF does not inactivate the T. californica
enzyme significantly more than does 0.5% methanol, even under the
extremely high concentrations used (4 mM).
The inactivation by BSF of T. californica AChE, mouse
wild-type AChE, and several mouse mutants was examined in the absence of substrate. Figure 5 shows the plot of
k' versus [BSF] for wild-type mouse AChE. This
inactivation shows saturation kinetics and the data were analyzed using
eq. 1 as described under Materials and Methods.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 5.
The rate constant, k', for the
inactivation of wild-type mouse AChE in the absence of substrate as a
function of [BSF]. Data were analyzed as described under
Materials and Methods.
|
|
BSF inactivation of AChE was also examined in the presence of substrate
for wild-type T. californica, mouse, and both T. californica and mouse mutants, as will be described below. Table
2 gives values of
k2, KI, and
k2/KI for BSF
inhibition in both the presence and absence of substrate. BSF reacts
measurably with all enzymes assayed.
The two mutants assayed in the absence of substrate, mouse Y330F
and mouse Y330A, have
k2/KI values of
50 and 100 M
1 min
1,
respectively. Again, these values are not significantly different from
the original mouse AChE
k2/KI. These
results confirm previous reports that BSF inhibits both mammalian and
T. californica AChE (Barnett and Rosenberry, 1978
) and show
that mouse mutations at position 330 to the residues of either T. californica AChE (Y330F) or mouse BChE (Y330A) do not affect the
inactivation significantly.
BSF inactivation of AChE in the presence of substrate
(acetylthiocholine) was measured as follows: product formation was
measured as a function of time for AChE in the presence of BSF and the resulting data were analyzed according to eq. 5 as described under Materials and Methods to obtain k' and
k2/KI values,
as shown in Fig. 6.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 6.
Plot of 1/(1 ) versus
[I]/k' for the inactivation of T.
californica F288L/F290I in the presence of 0.12 mM BSF, fit to
eq. 3. The slope equals
k2/KI as
described under Materials and Methods.
|
|
BSF inactivation in the presence of substrate gives
k2/KI values
with smaller associated error terms than for the absence of substrate
assay for both wild-type T. californica and mouse, but in
both cases, the two sets of data are consistent. Wild-type T. californica and mouse AChE have fairly slow rates of inactivation by BSF (k2/KI = 44 and 110 M
1 min
1,
respectively). Mutations in F288 and F290 have been shown to convert
the acyl pocket of AChE to that of BChE (Harel et al., 1992
; Vellom et
al., 1993
). All such acyl pocket mutations tested (Mouse F288L and
F290I and T. californica F288I/F290V) greatly accelerate the
rate of inactivation of the enzyme by BSF. Although the data are
associated with larger errors for the individual rate and dissociation
constants, it seems that at least some of the rate enhancement comes
from better binding (KI), whereas some may
also come from an accelerated sulfonylation reaction
(k2), perhaps because of better BSF
positioning in the mutant enzymes. Either the larger pocket can better
accommodate the bulky benzene group or better position it to attack or
the active site gorge as a whole is rendered more flexible, allowing
BSF in more readily.
PMSF inactivation of various AChEs was studied both in the absence and
presence of substrate. The plot of k' versus [PMSF] for
wild-type mouse AChE in the absence of substrate is shown in Fig.
7. Although the concentration of PMSF was
not high enough to saturate the enzyme, the data could still be
analyzed as above for BSF to obtain k2 and
KI values. Data from inactivation in the
presence of substrate were analyzed as for BSF as well.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 7.
The rate constant, k', for the
inactivation of wild-type mouse AChE in the absence of substrate as a
function of [PMSF]. The data were analyzed as described under
Materials and Methods.
|
|
The k2/KI
values for the inactivation by PMSF of wild-type T. californica and mouse AChEs, mouse mutants Y330F, Y330A, F288L, and F290I, T. californica double mutant F288L/F290V, and
mouse BChE are shown in Table 3. Each
enzyme was assayed in both the absence and presence of substrate.
Comparison of the reactivities of BSF and PMSF in inactivating mouse
AChE (Tables 2 and 3) shows that BSF second-order inactivation constants for mouse AChEs are 10-fold less than PMSF second-order inactivation constants for the same enzyme. Despite the increased reactivity of PMSF over BSF for the mouse AChE and the close similarity in structure of the two enzymes, wild-type T. californica
AChE is inactivated by BSF, whereas PMSF has no effect on this
enzyme. The object of this study was to assess the influence of
various residues on this difference in reactivity.
The k2KI
values confirm the fact that wild-type T. californica AChE
is not inactivated by PMSF at all. Mouse AChE, on the other hand, is
inactivated by PMSF, with a
k2/KI value of
960 M
1 min
1. The
k2/KI values
for mouse Y330A and Y330F are of the same magnitude as the wild-type
mouse AChE; this indicates that mutating the mouse enzyme at position
330 does not significantly affect its PMSF sensitivity. This is in
contrast to the large change in specificity found for huperzine binding
to the enzyme on making these same mutations (Saxena et al., 1994
).
PMSF must bind to the enzyme at a location different than that of huperzine.
PMSF inactivates mouse BChE with a
k2/KI value
approximately 8- to 9-fold greater than that of mouse AChE (Table 3),
indicating that the large acyl pocket of BChE is important for
accommodating PMSF. We therefore investigated the effects on PMSF
inactivation of mutating positions 288 and 290 in both mouse and
T. californica AChEs. The mutations F288L and F290I convert
mouse AChE residues to those normally present in mouse BChE. If these
positions are those primarily responsible for the difference in
inactivation between AChE and BChE, then we would expect that mutating
mouse AChE to residues present in BChE at these positions would
increase inactivation rates. Indeed, the
k2/KI values of
F288L and F290I, which are 16,000 and 56,000 M
1
min
1 in the presence of substrate,
respectively, show this expected increase in rate of inactivation
(Table 3). Unexpectedly, however, T. californica F288L/F290V
showed a much more dramatic increase in inactivation by PMSF. In fact,
these mutations caused the enzyme to change its behavior from
completely insensitive to PMSF to a
k2/KI value of
6000 M
1 min
1, behavior
in the same range as the mouse acyl pocket mutants. We expected that
the difference in sensitivity of mouse and T. californica
AChE to PMSF would be a result of differences in amino acid sequence.
However, mutation of residues that were the same in both species
resulted in loss of the difference in sensitivity.
PMSF Inhibition of BSF Inactivation.
It remains unclear why
T. californica AChE is insensitive to PMSF while it is
inactivated by BSF. The difference in inactivation might be caused by
one of two factors: 1) PMSF may be unable to bind in the T. californica active site gorge or 2) PMSF may be unable to orient
within the gorge to sulfonylate the T. californica AChE. To
determine which factor is responsible, T. californica AChE
was assayed with both PMSF and BSF simultaneously to observe the
ability of PMSF to competitively inhibit BSF inactivation. BSF (1.5 mM)
and various concentrations of PMSF were added to the enzyme solution at
time zero, after which the same procedure (described above) was
followed to measure BSF inactivation in the absence of substrate. If
PMSF cannot bind at all in the active site gorge, we would expect the
k' values for BSF to remain constant regardless of the
concentration of PMSF. This is exactly what happens (data not shown),
indicating that no competitive inhibition is occurring.
The results of the PMSF/BSF competition studies seem to indicate
that PMSF fails to inactivate T. californica AChE because of
an inability to bind in the active site gorge. This is a surprising result, because there are many hydrophobic inhibitors of AChE that are
larger than PMSF that are able to enter and bind in the active site
gorge. Nevertheless, if PMSF is unable to bind in the gorge, then one
of the residues lining the gorge that differ between T. californica and mouse AChE should be responsible for blocking the
active site. However, altering residues 288 and 290, which lie within
the gorge but are the same for mouse and T. californica, results in an enzyme that is now able to accommodate PMSF productively within the gorge. This observation suggests that there may be "breathing" motions that are different between mouse and T. californica that restrict PMSF orientation in the native T. californica enzyme. These breathing motions may be less restricted
in the F288L/F290V T. californica mutant, thus permitting
accomodation of PMSF. The source of the differences in these motions
between native mouse and T. californica enzymes may be
difficult to find, because they need not be the result of differing
amino acid residues in the active site gorge itself, but in more
distant parts of the protein. Although we previously thought that a
complete study of the active-site residues that are different in the
mouse and T. californica enzymes would clarify the
structural basis for the difference in PMSF specificity, we now think
that looking at mutations that change the breathing characteristics of
the enzyme may be more productive. Morel et al. (1999)
have reported
that a mutation in the T. californica enzyme, L282A (a
residue that is the same in Torpedo and mouse), has decreased
temperature stability (decreased enthalpy of activation for heat
denaturation) that also confers increased reactivity of C231 with thiol
reagents. This seems to suggest an increase in breathing of the mutant
so as to allow thiol reagents access to C231 (a buried residue). We
have preliminary data showing that T. californica L282A is
inactivated by PMSF (manuscript in preparation). This supports the idea
that the thermal instability reflects increased breathing motions and
that these motions are connected with PMSF sensitivity.
J.G.V. thanks Cristy DeLaCruz, Rebecca Schultz, Tari Suprapto,
and Leena Kansal for preliminary work on the project. The generous support of Tania Friedman is gratefully acknowledged.
This work was supported by grants from the Howard Hughes
Medical Institute, Swarthmore College Faculty Research Fund, the James
H. Hammons Chair Endowment (J.G.V.), the U.S. Army Medical and Materiel
Command under Contract Nos. DAMD17-97-2-7022 and DAMD 1718014, the
European Union 4th Framework Program in Biotechnology, the Kimmelman
Center for Biomolecular Structure and Assembly (Rehovot, Israel),
National Institutes of Health Grant GM18360, and the Dana Foundation.
I.S. is Bernstein-Mason Professor of Neurochemistry.
AChE, acetylcholinesterase;
ACh, acetylcholine;
BChE, butyrylcholinesterase;
PMSF, phenylmethylsulfonyl fluoride;
BSF, benzenesulfonyl fluoride;
ATC, acetylthiocholine chloride;
FA, fractional activity.